Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

HealthRock to promote health education

The $1 trillion cost and massive government role envisioned by the Obama Administration’s health care reform plan (The Affordable Health Choices Act of 2009) continue to create controversy in Congress and throughout the nation.

23 Sep 2009

Sanofi Pasteur receives additional order H1N1 vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the company has received an additional order from the U.S. Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose.

22 Sep 2009

Event: How to prepare for flu season and reduce spread of H1N1

HHS Secretary Kathleen Sebelius and Education Secretary Arne Duncan will hold a town hall meeting with students and faculty at George Mason University to discuss how to prepare for flu season and reduce the spread of the H1N1 virus on September 22, 2009.

22 Sep 2009

Millions of H1N1 healthcare consent forms - how to manage them?

As health officials prepare to roll out millions of H1N1 swine flu vaccines this fall, many are contemplating whether to get the shot or risk coming down with the illness. Yet for officials at the state and local level, the question isn’t whether to get the shot, but what to do with the millions of pages of healthcare forms that will begin piling up once the shot becomes available later this year.

22 Sep 2009

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

22 Sep 2009

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

22 Sep 2009

T-System revises its H1N1 point-of-care charting templates

T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).

22 Sep 2009

CDC recommends seasonal influenza vaccination to counter H1N1

Public health experts, including the Centers for Disease Control and Prevention (CDC), recommend seasonal influenza vaccination as the first line of defense this year in protecting against the influenza virus.

22 Sep 2009

PeriGen’s protocol bundle to prevent H1N1 in pregnant women

PeriGen, Inc., today announced the release of its Influenza Prevention and Treatment Bundle to its North American client hospitals. In advance of the approaching flu season, PeriGen’s protocol bundle will help clinicians follow recommended guidelines for screening, preventing and treating as well as accurately reporting cases of seasonal flu and H1N1 (“Swine Flu”) to state and local officials.

22 Sep 2009

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.

22 Sep 2009

U.S. hospital emergency departments not equipped to care for children

According to a recent IOM report, only 6 percent of U.S. hospital emergency departments are fully equipped to properly care for children. With high rates of novel H1N1 (swine) flu expected this winter, the time to address these deficiencies is immediate.

22 Sep 2009

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

22 Sep 2009

Bi-directional health information exchange to deal with disease outbreaks

Building upon four decades of research and real world operation of electronic medical records and health information exchange, Regenstrief Institute researchers have developed, tested and are now operating innovative technologies to allow for the bi-directional flow of evidence-based medical information between clinical sources and public health organizations.

22 Sep 2009

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

LSA (Language Services Associates), a leading provider of premium language-based solutions, today announced its comprehensive business continuity plan (BCP) for the 2009-2010 flu season. The strategy, which was devised by LSA’s BCP project management team, has been created to ensure the company is prepared for an increase in demand for language assistance in the event of a potential Swine Flu pandemic.

22 Sep 2009

Update from Cannabis Science regarding its phytocannabinoid pharmaceutical products

Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report progress for its phytocannabinoid pharmaceutical products to help reduce ARDS-associated deaths from both the Avian and Swine Influenza infections.

22 Sep 2009

Older adults with vitamin D deficiency at a greater risk of heart disease and death

A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.

22 Sep 2009

Duke University awarded $19.5M to design a portable viral infection detection device

The Defense Advanced Research Projects Agency (DARPA), the research arm of the U.S. Department of Defense, has awarded Duke University $19.5 million for an effort led by the Duke Institute for Genome Sciences & Policy (IGSP) to design a portable, easy-to-use diagnostic device that can reveal who is infected with an upper respiratory virus before the first cough or sneeze.

22 Sep 2009

U.N. report calls for $1.48B to help developing nations cope with H1N1

The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to help developing countries fight H1N1 (swine flu), Bloomberg reports. "Most of the money is needed for vaccines and drugs … to help the least-developed nations cope with the influenza pandemic, according to a U.N. report obtained" Monday by the news service.

21 Sep 2009

Also in Global Health news: HIV/aids in Zambia; Ugandan medical workers; Obama administration officials' Q&A, speech; South African health care reform efforts; texting to combat drug shortages in Africa

The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).

21 Sep 2009

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).

21 Sep 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

HealthRock to promote health education

Sanofi Pasteur receives additional order H1N1 vaccine

Event: How to prepare for flu season and reduce spread of H1N1

Millions of H1N1 healthcare consent forms - how to manage them?

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

FemSoft from Rochester Medical included in the UK Drug Tariff

T-System revises its H1N1 point-of-care charting templates

CDC recommends seasonal influenza vaccination to counter H1N1

PeriGen’s protocol bundle to prevent H1N1 in pregnant women

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

U.S. hospital emergency departments not equipped to care for children

Results from a trial testing a 2009 H1N1 influenza vaccine in children look promising

Bi-directional health information exchange to deal with disease outbreaks

LSA's BCP in place to tackle demand for language assistance in the event of a potential swine flu pandemic

Update from Cannabis Science regarding its phytocannabinoid pharmaceutical products

Older adults with vitamin D deficiency at a greater risk of heart disease and death

Duke University awarded $19.5M to design a portable viral infection detection device

U.N. report calls for $1.48B to help developing nations cope with H1N1

Also in Global Health news: HIV/aids in Zambia; Ugandan medical workers; Obama administration officials' Q&A, speech; South African health care reform efforts; texting to combat drug shortages in Africa

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in